Generali Investments, Management CO LLC Biogen Inc. Transaction History
Generali Investments, Management CO LLC
- $479 Billion
- Q3 2025
A detailed history of Generali Investments, Management CO LLC transactions in Biogen Inc. stock. As of the latest transaction made, Generali Investments, Management CO LLC holds 9,970 shares of BIIB stock, worth $1.67 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
9,970
Previous 1,962
408.15%
Holding current value
$1.67 Million
Previous $246 Million
467.56%
% of portfolio
0.29%
Previous 0.06%
Shares
3 transactions
Others Institutions Holding BIIB
# of Institutions
1,074Shares Held
131MCall Options Held
3.77MPut Options Held
2.31M-
Vanguard Group Inc Valley Forge, PA17.3MShares$2.9 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15MShares$2.51 Billion1.66% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.44 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.32MShares$1.23 Billion0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.25MShares$712 Million0.11% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $24.1B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...